Alaunos Therapeutics, Inc. (TCRT)
USD 2.51
(-5.99%)
USD 2.51
(-5.99%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 5000.00 | 2.92 Million | 398 Thousand | - | - | 146 Thousand |
| Cost of Revenue | 4.8 Million | 2.75 Million | 740 Thousand | 1.12 Million | 629 Thousand | - |
| Gross Profit | -4.79 Million | 163 Thousand | -342 Thousand | -1.12 Million | -629 Thousand | 146 Thousand |
| Operating Expenses | 29.46 Million | 38.16 Million | 77.2 Million | 80.36 Million | 57.85 Million | 54.05 Million |
| Selling, General and Administrative Expenses | 12.21 Million | 13.14 Million | 27.56 Million | 27.66 Million | 19.52 Million | 19.91 Million |
| Research and Development Expenses | 16.27 Million | 25.01 Million | 49.64 Million | 52.69 Million | 38.33 Million | 34.13 Million |
| Other Expenses | 971 Thousand | 529 Thousand | -1.2 Million | 385 Thousand | 813 Thousand | 631 Thousand |
| Cost and Expenses | 34.27 Million | 38.16 Million | 77.2 Million | 80.36 Million | 57.85 Million | 54.05 Million |
| Operating Income | -34.26 Million | -35.1 Million | -77.54 Million | -80.36 Million | 2.26 Million | -53.9 Million |
| Interest Expense | 1.92 Million | 3.15 Million | 1.18 Million | - | - | - |
| Income Tax Expense | - | -133 Thousand | -1.85 Million | -1.12 Million | 60.12 Million | -947 Thousand |
| Earnings before Tax | -35.14 Million | -37.73 Million | -78.75 Million | -79.97 Million | -117.79 Million | -53.11 Million |
| Net Income | -35.14 Million | -37.59 Million | -76.89 Million | -78.84 Million | -177.91 Million | -53.11 Million |
| Earnings Per Share Basic | -21.97 | -25.97 | -53.80 | -56.42 | -158.90 | -55.52 |
| Earnings Per Share Diluted | -21.97 | -25.97 | -53.80 | -56.42 | -158.90 | -55.44 |
| Weighted Average Shares Outstanding | 1.59 Million | 1.44 Million | 1.42 Million | 1.39 Million | 1.11 Million | 956.72 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 1.59 Million | 1.44 Million | 1.42 Million | 1.39 Million | 1.11 Million | 958.06 Thousand |
| Gross Margin | -959.60 | 0.06 | -0.86 | - | - | 1.00 |
| EBIT Margin | -6180.80 | -11.88 | -191.13 | - | - | -370.30 |
| Profit Margin | -7028.00 | -12.87 | -193.20 | - | - | -363.82 |
| EBITDA | -30.9 Million | -31.81 Million | -74.97 Million | -78.84 Million | -117.16 Million | -53.33 Million |
| Earnings Before Tax Margin | -6853.40 | -12.01 | -194.85 | - | - | -369.22 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 4000.00 | 1000.00 | 1000.00 | 5000.00 | - | 4000.00 |
| Cost of Revenue | 1000.00 | 2000.00 | 241 Thousand | 2.31 Million | 1.06 Million | 1.53 Million |
| Gross Profit | 3000.00 | -1000.00 | -240 Thousand | -2.31 Million | -1.06 Million | -1.52 Million |
| Operating Expenses | 1.16 Million | 1.74 Million | 3.12 Million | 26.18 Million | 7.23 Million | 8.23 Million |
| Selling, General and Administrative Expenses | 989 Thousand | 1.61 Million | 2.18 Million | - | 3.57 Million | 3.04 Million |
| Research and Development Expenses | 180 Thousand | 126 Thousand | 933 Thousand | - | 3.65 Million | 5.18 Million |
| Other Expenses | 37 Thousand | 60 Thousand | 106 Thousand | 1.04 Million | 188 Thousand | 277 Thousand |
| Cost and Expenses | 1.17 Million | 1.74 Million | 3.36 Million | 28.49 Million | 7.23 Million | 8.23 Million |
| Operating Income | -1.16 Million | -1.74 Million | -3.36 Million | -28.49 Million | -8.66 Million | -7.98 Million |
| Interest Expense | - | - | -3.84 Million | 1.92 Million | - | 1.06 Million |
| Income Tax Expense | - | -41.27 Thousand | -837 Thousand | 2.14 Million | 188 Thousand | 1.34 Million |
| Earnings before Tax | -1.12 Million | -1.68 Million | -7.84 Million | -35.14 Million | -8.47 Million | -8.77 Million |
| Net Income | -1.12 Million | -1.68 Million | -7.84 Million | -35.14 Million | -8.47 Million | -8.77 Million |
| Earnings Per Share Basic | -0.71 | -0.11 | -0.49 | - | -0.53 | -0.55 |
| Earnings Per Share Diluted | -0.71 | -0.11 | -0.49 | - | -0.53 | -0.55 |
| Weighted Average Shares Outstanding | 1.6 Million | 16.01 Million | 16.01 Million | 15.99 Million | 16 Million | 15.98 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.6 Million | 16.01 Million | 16.01 Million | 15.99 Million | 16 Million | 15.98 Million |
| Gross Margin | 0.75 | -1.00 | -240.00 | -462.00 | - | -382.25 |
| EBIT Margin | -291.25 | -1740.00 | -3119.00 | - | - | -1812.75 |
| Profit Margin | -282.25 | -1682.00 | -7843.00 | -7028.00 | - | -2193.25 |
| EBITDA | -1.16 Million | -1.74 Million | -3.11 Million | - | -6.36 Million | -7.25 Million |
| Earnings Before Tax Margin | -291.50 | -1742.00 | -3360.00 | -5698.60 | - | -1995.50 |
YBOX
CGBD
TMOAY
BEP-UN
TITAN
MTLHY